BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12711123)

  • 61. Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.
    Jawahar A; Matthew RE; Minagar A; Shukla D; Zhang JH; Willis BK; Ampil F; Nanda A
    J Neurosurg; 2004 May; 100(5):842-7. PubMed ID: 15137603
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of long-term survivors with small-cell lung cancer.
    Skarin AT
    Chest; 1993 Apr; 103(4 Suppl):440S-444S. PubMed ID: 8384976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
    Evans WK; Radwi A; Tomiak E; Logan DM; Martins H; Stewart DJ; Goss G; Maroun JA; Dahrouge S
    Am J Clin Oncol; 1995 Apr; 18(2):149-55. PubMed ID: 7534977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation.
    Myers JN; O'neil KM; Walsh TE; Hoffmeister KJ; Venzon DJ; Johnson BE
    Chest; 2005 Nov; 128(5):3261-8. PubMed ID: 16304271
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].
    Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S
    Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control.
    Videtic GM; Fung K; Tomiak AT; Stitt LW; Dar AR; Truong PT; Yu EW; Vincent MD; Kocha WI
    Lung Cancer; 2001; 33(2-3):249-58. PubMed ID: 11551420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation and radiotherapy implications of chest relapse patterns in small cell lung carcinoma treated with radiotherapy-chemotherapy: study of 34 cases and review of the literature.
    Mira JG; Livingston RB
    Cancer; 1980 Dec; 46(12):2557-65. PubMed ID: 6256050
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Patterns of relapse in patients with small cell lung cancer--the effect of chest irradiation and prophylactic cranial irradiation combined with intensive chemotherapy on long-term survival].
    Ueoka H; Ohnoshi T; Numata T; Kawahara S; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K; Uji H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1581-7. PubMed ID: 1963910
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer.
    Chute JP; Kelley MJ; Venzon D; Williams J; Roberts A; Johnson BE
    Chest; 1996 Jul; 110(1):165-71. PubMed ID: 8681622
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).
    Lara PN; Chansky K; Davies AM; Franklin WA; Gumerlock PH; Guaglianone PP; Atkins JN; Farneth N; Mack PC; Crowley JJ; Gandara DR
    J Thorac Oncol; 2006 Nov; 1(9):996-1001. PubMed ID: 17409985
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term survivors of small cell carcinoma of the lung.
    Vogelsang GB; Abeloff MD; Ettinger DS; Booker SV
    Am J Med; 1985 Jul; 79(1):49-56. PubMed ID: 2990209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term survival in patients with small cell lung cancer.
    Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Sano T; Ono R; Takahashi H
    Jpn J Clin Oncol; 1986 Sep; 16(3):309-15. PubMed ID: 3022039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of low-dose chest irradiation before chemotherapy on the rate of local failure in small-cell lung cancer.
    Hösli P; Bonnefoi H; Mirimanoff RO; Mermillod B; Alberto P
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):287-9. PubMed ID: 9607343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
    Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
    J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 76. First-line chemotherapy rechallenge after relapse in small cell lung cancer.
    Vincent M; Evans B; Smith I
    Cancer Chemother Pharmacol; 1988; 21(1):45-8. PubMed ID: 2830043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
    Johnson DH; Greco FA; Strupp J; Hande KR; Hainsworth JD
    J Clin Oncol; 1990 Oct; 8(10):1613-7. PubMed ID: 2170589
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.
    Arriagada R; Kramar A; Le Chevalier T; De Cremoux H
    J Clin Oncol; 1992 Mar; 10(3):447-51. PubMed ID: 1311025
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer.
    Shepherd FA; Ginsberg RJ; Evans WK; Feld R; Cooper JD; Ilves R; Todd TR; Pearson FG; Waters PF; Baker MA
    J Thorac Cardiovasc Surg; 1983 Oct; 86(4):498-506. PubMed ID: 6312199
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: the potential for cure.
    Mac Manus MP; Wada M; Matthews JP; Ball DL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):63-9. PubMed ID: 10656374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.